BEGIN:VCALENDAR VERSION:2.0 PRODID:-//wp-events-plugin.com//7.2.3.1//EN TZID:America/Phoenix X-WR-TIMEZONE:America/Phoenix BEGIN:VEVENT UID:1577@azbio.org DTSTART;TZID=America/Phoenix:20210921T080000 DTEND;TZID=America/Phoenix:20210921T090000 DTSTAMP:20210519T201714Z URL:https://www.azbio.org/events/health-economics-part-1-health-economics- discussion-panel SUMMARY:AZBioPEERS: Health Economics Part 1: Health Economics & How to Pric e A Product - - 21 Sep 21 08:00 DESCRIPTION:\nHealth Economics Part 1: Health Economics &\; How to Price a Product\nTuesday September 21st\, 2021   08:00 – 09:00 AM\n\nFeature d Speaker:\n\n Dr. Ivo Abraham\, PhD\, RN - Professor of Pharmacy Practi ce and Science\, University of Arizona College of Pharmacy\n\nSession Lea d: Joan Koerber-Walker\n\nPlease join us for an overview of Health Econo mics and why it is important for early stage companies to perform health e conomic evaluations of their products. \n\n What are the elements that g o into product pricing?\n How do you position a product into the payment chain?\n What are the factors and trade offs when pricing your product?\n \n \;\nREGISTER\n\nAbout Our Speaker:\n \;\nIvo Abraham\, PhD\, RN \n\n\n\n\n\nProfessor\, Pharmacy Practice and Science - University of Ari zona College of Pharmacy\n\n\n\n\n\n\n\n\n\n\n\n\nIvo Abraham is a profess or (part-time) in the Department of Pharmacy Practice. He has also served on the faculty of Case Western Reserve University (Cleveland\, Ohio)\, Uni versity of Virginia (Charlottesville\, Va.)\, and (part-time) Katholieke U niversiteit Leuven (Leuven\, Belgium)\; and as visiting professor at Unive rsiteit Maastricht (Maastricht\, The Netherlands)\, University of Florida (Gainesville\, Fla.)\, Rijksuniversiteit Groningen (Groningen\, The Nether lands)\, University of Pennsylvania (Philadelphia\, Penn.)\, and Chang Gun g University (Kwei-Shan Tao-Yuan\, Taiwan).  He has lectured\, consulted\ , and conducted research throughout the Americas\, Europe\, the Asia-Pacif ic region\, and Africa. Being part-time\, he divides his time between the University of Arizona and Matrix45\, a biopharmaceutical research and cons ulting company\, where he serves as chief scientist.\n\nFor the past decad e or so\, Dr. Abraham’s research has focused mainly on clinical outcomes and effectiveness research\, in particular how variability in (drug-centr ic) treatment regimens is associated with variability in patient outcomes. However\, instead of merely evaluating effectiveness (does the treatment work?)\, the work of his research group addresses the equally important qu estions of when does the treatment work (and when not)\, what influences w hether the treatment works\, why does the treatment work in some patients but not in others\, why does the treatment work with some clinicians but n ot with others\, why is the treatment tolerated by some patients but not b y others\, and how much of patient outcomes is related to patient vs. clin ician or treatment center?  In this process\, his group uses a comprehens ive framework of treatment patterns and outcomes assessment\, vulnerabilit y profiling\, hierarchical modeling\, (non-)responder analysis\, and pharm acovigilance and drawing methodologies and statistical models from other d isciplines into biomedical research.\n\nMore recently\, frustrated by the abundance of evidence but clinicians’ persistent low adoption of evidenc e-based guidelines\, he and his colleagues started examining how practicin g in accordance with evidence-based guidelines is directly associated with patient outcomes.\n\nHe has (co-)authored 260+ articles and 60+ chapters\ , and has (co-)edited 29 books\, monographs\, and journal issues. Since 19 84\, his research has been funded by federal funding agencies\, foundation s\, and corporations.   He has served as appointed ad hoc reviewer for th e NIH\, the NIMH\, and the AHRQ. He currently serves as an expert adviser to the Innovative Medicines Initiative\, a joint 2 billion euro undertaki ng of the European Union and the biopharmaceutical industry to stimulate i nnovation in human therapeutics.\n\nHis educational and scientific honors and awards include an Invitational research fellowship from the Japan Soci ety for the Promotion of Science (2007-2008)\, which he conducted at Hyogo University and Aomori University.\n\n\n\n\n\n \; CATEGORIES:webinars END:VEVENT BEGIN:VTIMEZONE TZID:America/Phoenix X-LIC-LOCATION:America/Phoenix BEGIN:STANDARD DTSTART:20200921T080000 TZOFFSETFROM:-0700 TZOFFSETTO:-0700 TZNAME:MST END:STANDARD END:VTIMEZONE END:VCALENDAR